The spatial omics market has seen considerable growth due to a variety of factors.
• The spatial omics market has grown rapidly in recent years. It will rise from $0.3 billion in 2024 to $0.33 billion in 2025 at a CAGR of 11.7%.
The growth is driven by the increasing prevalence of genetic disorders, rising cancer rates, growing demand for personalized medicine, the need for biomarker identification, and the adoption of spatial genomics and other omics technologies.
The spatial omics market is expected to maintain its strong growth trajectory in upcoming years.
• The spatial omics market is expected to grow rapidly, reaching $0.51 billion by 2029 at a CAGR of 11.3%.
Growth drivers include increased R&D, more funding for OMICS research, cancer biomarker discovery, translational research, and economic growth. Key trends include strategic collaborations, spatial omics techniques, technology integration, product innovations, and technological advancements.
The increase in genetic ailments is set to fuel the expansion of the spatial omics market. Genetic disorders, which are a result of inherited DNA abnormalities from one or both parents, are on the rise due to heightened awareness, advanced diagnostic methods, lifestyle shifts, and environmental agents leading to mutations. Spatial omics methods present a robust way of examining genetic disorders, delivering in-depth spatial maps of molecular and genetic traits within tissues. For example, the World Health Organization (WHO) reported in February 2023 that globally, congenital illnesses were responsible for roughly 240,000 infant mortalities within their first 28 days of life each year. Further, according to the U.S. government's Centers for Disease Control and Prevention, approximately 6,000 babies with Down syndrome are born in America each year, equating to about 1 in every 700 babies. Thus, the increasing occurrence of genetic disorders is spurring the growth of the spatial omics market.
The spatial omics market covered in this report is segmented –
1) By Product: Instruments, Consumables, Software
2) By Sample Type: Formalin-Fixed Paraffin-Embedded (FFPE), Fresh Frozen
3) By Workflow: Sample Preparation, Instrumental Analysis, Data Analysis
4) By Technology: Spatial Transcriptomics, Spatial Genomics, Spatial Proteomics
5) By End-Use: Academic And Translational Research Institutes, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Instruments: Spatial Transcriptomics Instruments, Imaging Systems, Mass Spectrometers
2) By Consumables: Reagents, Kits, Sample Preparation Materials
3) By Software: Data Analysis Software, Visualization Tools, Integration Platforms
Leading enterprises in the spatial omics industry are enhancing their product offerings with advanced technology like high-plex spatial imaging to improve customer experience. This groundbreaking technique enables comprehensive visualization of multiple molecular markers within a single tissue sample, preserving spatial context and supporting in-depth study of complex cellular interactions and tissue architecture. For example, US-based biotech firm Standard BioTools Inc. unveiled the Hyperion+ Imaging System in April 2022. The system significantly advances spatial biology research by offering high-parameter imaging capabilities. It integrates Imaging Mass Cytometry (IMC) technology and superior automation, enabling the concurrent study of 40 or more protein markers at subcellular resolution without the hindrance of autofluorescence. The Hyperion+ system is built for high performance, possessing the capacity to process up to 100 samples weekly and manage 140 tissue microarrays in just over five days, making it highly beneficial for large-scale studies.
Major companies operating in the spatial omics market are:
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Ilumina Inc.
• Bruker Corporation
• QIAGEN N.V.
• 10x Genomics Inc.
• Luminex Corporation
• Takara Bio Inc.
• Oxford Nanopore Technologies
• NanoString Technologies Inc.
• Standard BioTools Inc.
• Akoya Biosciences Inc.
• CrestOptics
• Indica Labs Inc.
• Miroculus Inc.
• Resolve Biosciences GmbH
• Pixelgen Technologies
• Ionpath Inc.
• RareCyte Inc.
• S2 Genomics Inc.
• Spatial Genomics
• Vizgen Inc.
• BioSpyder Technologies
• Ultivue Inc.
• Seven Bridges Genomics
North America was the largest region in the Spatial OMICS market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spatial omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.